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CDK5RAP1We illuminate the metabolism and the cell-signaling activities of inositol pyrophosphates, by show-
ing that regulation of yeast cyclin-kinase by 1-InsP7 is not conserved for mammalian CDK5, and by
kinetically characterizing Ddp1p/DIPP-mediated dephosphorylation of 1-InsP7, 5-InsP7 and InsP8.
Each phosphatase exhibited similar Km values for every substrate (range: 35–148 nM). The rank
order of kcat values (1-InsP7 > 5-InsP7 = InsP8) was identical for each enzyme, although DIPP1 was
10- to 60-fold more active than DIPP2a/b and DIPP3a/b. We demonstrate InsP8 dephosphorylation
preferentially progresses through 1-InsP7. Conversely, we conclude that the more metabolically
and functionally signiﬁcant steady-state route of InsP8 synthesis proceeds via 5-InsP7.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Among the many members of the inositol phosphate signaling
family, the diphosphoinositol polyphosphates (inositol pyrophos-
phates;1-InsP7, 5-InsP7 and InsP8) receive particular attention.
These ‘‘high-energy’’ signals operate at the interface of cell signal-
ing and metabolic homeostasis [1,2], by phosphorylating proteins
[3] (but see [4]), by regulating transcriptional responses to envi-
ronmental stress [5–7], and by modulating PtdIns(3,4,5)P3-signal-
ing [8,9].
Understanding metabolic regulation of inositol pyrophosphate
turnover reveals how this signaling cascade is controlled. Indeed,
no metabolic pathways can be modeled accurately without knowl-
edge of the kinetic parameters of the participating enzymes [10].
Inositol pyrophosphate metabolism is complicated by the two
kinase pathways from InsP6 to InsP8 (I and II; ref [11] and Fig. 1),
and by diphosphoinositol polyphosphate phosphohydrolases (DIPPs).
Another confounding factor is that humans express ﬁve DIPP iso-
forms: types 1, 2a, 2b, 3a and 3b [12–15]. Saccharomyces cerevisiae
only express one: the diadenosine and diphosphoinositol phospho-
hydrolase (Ddp1p) [16]. Little is known concerning the Michaelis–
Menten kinetic parameters for Ddp1p/DIPPs; no such data are pub-lished for 1-InsP7 and InsP8. While some kinetic data have been
provided for 5-InsP7, their reliability is now being questioned.
For instance, Km values for 5-InsP7 vary from 4 nM for DIPP1 [12]
to 4 lM for DIPP3b [15]. Such variation seems inconsistent with
the high conservation of the DIPP catalytic domain. Instead, recent
improvements in enzymatic [17] and chemical [18,19] methods for
synthesizing inositol pyrophosphates have called into question the
quality of some early sources of 5-InsP7 (see [18]). Here, using im-
proved methods for the enzymatic synthesis and electrophoretic
puriﬁcation of 1-InsP7, 5-InsP7 and InsP8 [17], we have kinetically
characterized the DIPP family.
2. Materials and methods
2.1. Materials
GST-DIPP3a and GST-DIPP3b were prepared as described [15].
GST-DIPPs 1, 2a and 2b plasmids [12,13] were subcloned from
pQE30 into pGEX6P-1 using BamHI and SalI. Expression plasmids
were transformed into Escherichia coli (BL21), and induced at
26 C overnight with 100 lM IPTG. Cells were harvested and soni-
cated in 20 mM Tris, 150 mM NaCl, 2 mM DTT, 0.1 mM EGTA, pH
7.5, 5 lg/ml leupeptin and 1 lg/ml aprotinin. GST-DIPPs were then
puriﬁed using a Glutathione Sepharose-4 Fast-Flow column (Amer-
sham Pharmacia Biotech). Protein was stored at 80 C in 10% v/v
glycerol. Professor A.G. McLennan kindly provided Ddp1p.
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Fig. 1. Metabolic interconversions of InsP6, InsP7 and InsP8. DIPP = diphosphoinos-
itol polyphosphate phosphohydrolase (Ddp1p in yeast); IP6K = inositol hexakis-
phosphate kinase (Kcs1p in yeast); PPIP5K = diphosphoinositol pentakisphosphate
kinase (Vip1p in yeast). Pathways I and II are named as in [11].
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IMAGE clone 4418659, subcloned into pENTR/TEV/D-TOPO, and
further subcloned into pDest606 in E. coli (DH5a). The
CDK5RAP1-pDest606 construct was transformed into E. coli
DH10Bac cells, yielding CDK5RAP1/bMON14272 bacmid; this was
ampliﬁed by successive infections of Sf9 cells, prior to infection
for protein expression. After 72 h., cells were lysed in I-Per (Pierce)
plus protease inhibitor cocktail (Roche). CDK5RAP1 was puriﬁed
using Ni-NTA resin and then an amylose resin column. Protein
was stored at 80 C.
InsP6 was obtained from Calbiochem. Enzymatically-prepared
inositol pyrophosphates were electrophoretically puriﬁed [17,20].
Samples from ‘‘blank’’ gels (i.e. no inositol pyrophosphates), pro-
cessed in parallel, provided vehicle controls. Purity (by HPLC) of
5-InsP7, 1-InsP7, and InsP8 was, respectively, 86%, 95% and 94%.
Such slight decomposition of the pyrophosphate groups does not
signiﬁcantly affect assays of DIPP activity [19]. Assays were cor-
rected for the ‘‘zero-time’’ products.
2.2. Assays
Phosphatase activity was determined at 30 C (Ddp1p) or 37 C
(DIPPs) in 20 ll of buffer containing 50 mM KCl, 50 mM HEPES (pH
7.2 with KOH), 4 mM CHAPS, 0.05 mg/ml BSA, 1 mM Na2EDTA,
2 mM MgSO4. [3H]labeled and non-radiolabeled InsP7 or InsP8
[20] were added as indicated (see Figures). After 2–25 min (corre-
sponding to approx. 20% substrate metabolism), reactions were
quenched and neutralized [14], loaded onto a HiChrom 4.6
 125 mm Partisphere 5lm SAX column, and eluted (1 ml/min)
with one of two protocols generated by mixing Buffer A (1 mM
Na2EDTA) with buffer B [A + 1.3 M (NH4)2HPO4, pH 3.85 with
H3PO4]: protocol 1), 0–5 min, B = 0%; 5–10 min, B = 0–45%; 10–
55 min, B = 45–100% (1 ml fractions); protocol 2), 0–5 min,
B = 0%; 5–10 min, B = 0–50%; 10–55 min, B = 50–100% (0.5 ml frac-
tions). [3H] was assayed by liquid scintillation spectrometry. Km
and kcat values were obtained by non-linear regression.
CDK5 activity was measured after preincubating (30 min) 50 ng
CDK5/p35 (Sigma) and 20 ng CDK5RAP1 in 45 ll reactions contain-
ing 20 mM MOPS pH 7.4, 1 mM EGTA, 20 mM MgCl2, 1 mM dithio-
threitol, 100 lM (c-32P)ATP (0.05 lCi) and the appropriate inositolphosphate. Reactions were initiated with 5 ll of 1 mg/ml peptide
substrate (BioMol International). After 30 min, 40 ll of each reac-
tion was quenched by spotting onto P81 phospho-cellulose ﬁlters
(Millipore). These were washed (4; 0.75% H3PO4) and acetone-
rinsed. [32P] was assayed by Cerenkov counting.
3. Results and discussion
3.1. Ddp1p kinetics
By HPLC analysis of the dephosphorylation of [3H]-radiolabeled
substrates, we have kinetically characterized recombinant Ddp1p
from S. cerevisiae. Ddp1p hydrolyzed 1-InsP7 and 5-InsP7 to InsP6
(Fig 2A,B). InsP8 was dephosphorylated to InsP6, with relatively lit-
tle accumulation of InsP7 (Fig. 2C, and see below). Substrate satu-
ration plots (Fig. 2) showed that Km values for each substrate
were very similar (93 nM, 105 nM, 148 nM; Table 1), but 1-InsP7
was hydrolyzed at a 5 to 6-fold faster rate than 5-InsP7 and InsP8
(Table 1).
No previous studies have described Michaelis–Menten kinetic
parameters for Ddp1p activity towards either 1-InsP7 or InsP8.
There is one earlier study [21] that incubated Ddp1p with
250 lM of either 1-InsP7 or 5-InsP7; in an electrophoretic analysis,
only 1-InsP7 was found to be dephosphorylated. That inability to
detect 5-InsP7 metabolism may have reﬂected its assay concentra-
tion exceeding the Km value by 3 orders of magnitude (see Table 1).
Also, SDS–PAGE mass analysis is less sensitive than is HPLC analy-
sis of [3H]-labeled substrates. So although the preference of Ddp1p
for 1-InsP7 over 5-InsP7 was previously known [21], our new ki-
netic data indicate the relative reaction rates are closer than previ-
ously suggested.
3.2. Human DIPP kinetics
We obtained substrate saturation plots (not shown) to derive
Km and kcat values for all ﬁve human DIPPs (Table 1). DIPP1 exhib-
ited the highest kcat, irrespective of substrate (Table 1). Thus, for
example, the relative levels of cellular expression of DIPP1, versus
the 20- to 60-fold less active DIPP2 isoforms, could dictate the
rapidity of inositol pyrophosphate turnover on a cell-to-cell basis.
This in turn could inﬂuence the sensitivity with which levels of
inositol pyrophosphates respond to appropriate stimuli. This is
analogous to how differential expression of cAMP-phosphodiester-
ases isoforms inﬂuence cell-to-cell differences in the sensitivity of
agonist-mediated cAMP signaling [22].
All human DIPPs behaved similarly to Ddp1p in exhibiting high-
er kcat values for 1-InsP7 compared to 5-InsP7 and InsP8 (Table 1).
The Km data only vary over a 4-fold range (35 to 148 nM), across
every enzyme and every substrate. The demonstration that rates
of InsP7 dephosphorylation equal or exceed those of InsP8 metabo-
lism (Table 1) explains why so little InsP7 accumulated when InsP8
was incubated with DIPPs (Fig. 3); the InsP7 was rapidly converted
to InsP6.
Our new kinetic data yield further conclusions: since cellular
levels of 5-InsP7 are about 1–2 lM [15,23], these can now be con-
sidered sufﬁcient (see Table 1) to be at a saturating concentration
for all DIPPs. The kcat values for 5-InsP7 dephosphorylation are 5 to
9-fold lower than those for 1-InsP7 (Table 1). However, the afﬁni-
ties of the two InsP7 isomers for DIPPs are similar (Table 1), so they
will compete for the DIPP active sites in direct proportion to their
cellular concentration ratios. In mammalian cells, steady-state
levels of 1-InsP7 are 10 to15-fold lower than those of 5-InsP7
[24]. Thus, in vivo it is unlikely that the steady-state rate of 1-InsP7
dephosphorylation will be signiﬁcantly greater than that for
5-InsP7. The latter conclusion – which can only be made now that
kinetic parameters are available (Table 1) – counters a recent pro-
Fig. 2. Analysis of the catalytic activities of Ddp1p. HPLC was used to obtain substrate saturation plots for Ddp1p against either A, 1-InsP7, (0–1024 nM incubated with 2 ng
Ddp1p for 0–25 min); B, 5-InsP7 (0–512 nM incubated with 8 ng Ddp1p for 0–25 min); or C, InsP8, (0–512 nM incubated with 8 ng Ddp1p for 0–25 min). Insets provide
illustrative HPLC analyses using protocol 1 (Section 2.2): (A) 10 nM 1-InsP7, 20 ng Ddp1p, 10 min (not used in the substrate saturation plot). (B) 10 nM 5-InsP7, 10 ng Ddp1p,
6 min (not used in the substrate saturation plot). (C) 16 nM InsP8, 8 ng Ddp1p, 4 min.
Table 1
Ddp1p/DIPP kinetic data.
1-InsP7 5-InsP7 InsP8
Km (nM) 102  kcat (s1) Km (nM) 102  kcat (s1) Km (nM) 102  kcat (s1)
Ddp1p 105 2.4 ± 0.05 93 0.4 ± 0.1 148 0.5 ± 0.1
DIPP1 42 110 ± 30 52 13 ± 3 85 10 ± 2
DIPP2a 60 5 ± 2 35 0.7 ± 0.2 55 0.24 ± 0.08
DIPP2b 70 1.7 ± 0.5 40 0.3 ± 0.09 42 0.16 ± 0.02
DIPP3a 104 23 ± 2 146 4 ± 2 126 2.2 ± 0.4
DIPP3b 73 8 ± 2 63 0.88 ± 0.07 78 0.37 ± 0.06
Kinetic data were obtained as described in Section 2. Average (n = 3–5) substrate afﬁnities were ﬁrst compiled as logKm (SEMs were < 3% of the mean) and then transformed
to Km for the Table.
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‘‘masks’’ its rate of kinase-mediated synthesis relative to that for 5-
InsP7.
3.3. Inositol pyrophosphates do not regulate the human homologue of
the yeast Pho80/81/85 cyclin kinase complex
The debate over the relative functional signiﬁcance of pathway I
and II (see above) has been inﬂuenced by the observation [5] that,
in yeast, 1-InsP7 reversibly empowers Pho81 to inhibit the Pho80/
85 cyclin kinase complex. This remains the only demonstration to
date that 1-InsP7 serves a unique biological function. The mamma-
lian homologs of Pho85 (the kinase), Pho80 (the kinase activator)
and Pho81 (the kinase inhibitor) are, respectively, CDK5, p35 and
CDK5RAP1 (originally: C42) [25,26]. However, unlike Pho81, there
is no evidence recombinant CDK5RAP1 requires ancillary factors
for inhibiting cyclin kinase activity [27].
In earlier experiments [6], 1-InsP7 augmented inhibition of
Pho85 by Pho81 when the latter was added at a molar ratio with
Pho85 that was 20- to 30-fold lower that which, by itself, inhibited
Pho85. In our CDK5 assays, we increased assay sensitivity by hav-
ing CDK5RAP1 at the threshold level at which its own inhibitory ef-
fects can be detected (Fig. 4). We then added 4 lM 1-InsP7, a
concentration that is >20-fold higher than is physiological (see
above); CDK5 activity was unaffected (Fig. 4B); InsP6, 5-InsP7 and
InsP8 were similarly ineffective (i.e. P > 0.05 vs controls) (Fig. 4B).
These data provide the ﬁrst evidence that speciﬁc regulation of
yeast cyclin kinase activity by 1-InsP7 [5] is not conserved in
mammals.Fig. 3. HPLC analyses of the hydrolysis of InsP8 by DIPP2b and DIPP3b. HPLC
analyses (protocol 1; Section 2.2) of the metabolism (ﬁlled circles) at 37 C of 16 nM
InsP8 incubated with (A) 10 ng DIPP2b for 6 min, or (B) 22.5 ng DIPP3b for 2 min.
Open circles depict zero-time controls.
Fig. 4. Inositol pyrophosphates do not regulate CDK5 activity. Panel A describes the
concentration-dependent inhibition of CDK5 activity by CDK5RAP1, measured as
described in Section 2. In panel B the molar ratio of CDK5RAP1:CDK5 was 0.4:1.
None of the added inositol phosphates (4 lM) affected CDK5 activity (P > 0.05 vs
vehicle control; analysis by ANOVA with a Dunnett’s post hoc test, n = 5–8). Further
experiments (not shown) did not uncover ‘‘order-of-addition’’ effects upon CDK5
activity.3.4. The positional speciﬁcity of DIPPs towards InsP8
The positional speciﬁcity of DIPPs towards the 1- and/or 5-
diphosphate groups on InsP8 also inﬂuences relative ﬂuxes through
the inositol pyrophosphate pathways (Fig. 1). Positional speciﬁcity
is difﬁcult to quantify, as so little InsP7 accumulates when InsP8 is
dephosphorylated by DIPPs (e.g. Fig 3). Furthermore,1-InsP7 and 5-
InsP7 are not generally resolved by strong anion-exchange HPLC.
However, the columns used in the current study yielded a partial
separation, particularly when we collected smaller fractions from
a shallower gradient (Fig. 5A).
During InsP8 dephosphorylation by Ddp1p, DIPP1, DIPP2a and
DIPP3a, the accumulation of new InsP7 product was 45–70% above
the level of the (predominantly) 1-InsP7 that was present in the no-
enzyme assays (Fig. 5). Both the increase in InsP7 peak height, and
the larger degree of peak spreading, were sufﬁcient to indicate
accumulation of both 1-InsP7 and 5-InsP7. However, the kcat data
in Table 1 allow us to conclude that, in these experiments
(Fig. 5), 1-InsP7 that is formed from InsP8 will be degraded faster
than the 5-InsP7 that is produced. That is, the rate of the 5-phos-
phate removal from InsP8 (yielding 1-InsP7) is underestimated
relative to the rate of 1-phosphate removal from InsP8 (producing
Fig. 5. HPLC analyses of InsP8 dephosphorylation by Ddp1p, DIPP1, DIPP2a and DIPP3a. Representative HPLC runs (protocol 2; Section 2.2) are shown for reactions containing
either no enzyme (A; ‘‘zero’’), or B, 16 ng Ddp1p, C, 2 ng DIPP1, D, 20 ng DIPP2a and E, 10 ng DIPP3a, all incubated for 8 min with 16 nM InsP8. The right hand panels in each
pair amplify the InsP7 region of the chromatograph (open circles; InsP7 is quantiﬁed as percentage of total); ﬁlled symbols show elution of 1-InsP7 and 5-InsP7 standards
(determined individually).
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Fig. 6. Metabolism of a 1:1 mixture of 1-InsP7 and 5-InsP7 by DIPP1. 1-InsP7 plus 5-
InsP7 (10 nM each) were together incubated for 10 min with 0.3 ng DIPP1 plus
approx 1000 D.P.M. of either 1-[3H]InsP7 (left hand bar) or 5-[3H]InsP7 (right-hand
bar). HPLC analysis determined the metabolism of each InsP7. ⁄P = 0.02 (t-test;
n = 3).
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DIPP1 metabolizes 1-InsP7 faster than 5-InsP7 from a 1:1 mixture.
Thus, where the data allow us to determine positional speciﬁcity
(Fig. 5), we conclude Ddp1p/DIPPs preferentially (but not exclu-
sively) remove the 5-phosphate from InsP8. Positional speciﬁcity
for DIPPs 2b/3b was less clear (Fig. 3), but based on sequence con-
servation and kinetic similarities, it seems likely they also show
positional selectivity for the 5-phosphate on InsP8. Thus, the pref-
erential route of InsP8 dephosphorylation is metabolically distinct
from the main pathway for InsP8 synthesis. This contrasts with
the old idea [28] that DIPPs remove from InsP8 the diphosphate
group that is added after 5-InsP7 (now known to be in the 1-posi-
tion [29]). The latter conclusion arose from a different experimen-
tal approach in which commercially-prepared substrates were
incubated with liver homogenates. It is unclear why the earlier
experiments led to a different conclusion – current concern over
the quality of the substrates used (see Section 1) could be relevant
here - but the possibility of a separate InsP8 phosphatase is another
option that bears some consideration.
3.5. Concluding comments
Our study increases insight into inositol pyrophosphate turn-
over and function in vivo by providing the ﬁrst kinetic characteriza-
tion of Ddp1p/DIPP-mediated hydrolysis of 1-InsP7, 5-InsP7 and
InsP8. Our results lead us to argue against previous suggestions
[11,21] (made in the absence of the relevant kinetic data) that
DIPPs conceal the importance of pathway II (see Fig. 1) by masking
the rate of PPIP5K-driven phosphorylation of InsP6 to1-InsP7. Fur-
thermore, much of the attention given to the functional signiﬁ-
cance of pathway II arises from evidence that 1-InsP7 inhibits the
yeast Pho85 cyclin kinase [5,6]. Our data (Fig. 4) indicate that this
mechanism is not conserved in mammals. Indeed, in mammals the
5-InsP7 that is produced by pathway I has functional signiﬁcance,
by competing with PtdIns(3,4,5)P3 for PH domains [8,9]; 1-InsP7
is much less potent [8].
The DIPP/Ddp1 family can also hydrolyze inorganic polyphos-
phates [21], 5-phosphoribosyl 1-pyrophosphate [30] and nucleo-
tide dimers [16]. However, these particular catalytic activities are
unlikely to affect the conclusions reached in this study, as they
have alkaline pH optima and are orders of magnitude slower than
the rates of inositol pyrophosphate hydrolysis.Although mammalian cells contain only submicromolar levels
of 1-InsP7 (Section 3.2), its concentration in S. cerevisiae has been
argued to reach 30 lM in phosphate-starved cells [5]. While others
have disputed that claim [21], it has nevertheless been reported
that, in ddp1D yeast, levels of (presumably) 1-InsP7 were elevated
5-fold upon inhibition of Kcs1p by TNP, or by kcs1 deletion [11].
Those experiments were proposed to reveal the true extent of stea-
dy-state 1-InsP7 synthesis, again arguing that Pathway II is under-
appreciated. However, perhaps in those experiments, Vip1p’s
phosphorylation of InsP6 was artiﬁcially enhanced merely because
of the absence of the kinase’s preferred (and competing) substrate,
5-InsP7 (see [20,29]).
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